These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18487234

  • 1. Heart-rate reduction and beta-blockade in early post-infarction cardiac remodelling.
    Goldstein RE, Haigney MC.
    Cardiovasc Res; 2008 Jul 01; 79(1):5-6. PubMed ID: 18487234
    [No Abstract] [Full Text] [Related]

  • 2. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M, Mackiewicz U.
    Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart.
    Gourine A, Bondar SI, Spyer KM, Gourine AV.
    Circ Res; 2008 Mar 28; 102(6):633-6. PubMed ID: 18323523
    [Abstract] [Full Text] [Related]

  • 4. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, El-Armouche A, de Beer VJ, Lamers JM, Carrier L, Walker LA, Linke WA, Stienen GJ, van der Velden J.
    Circ Heart Fail; 2009 May 28; 2(3):233-42. PubMed ID: 19808345
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular remodelling during treatment with beta-blockers.
    Ertl G, Hu K.
    J Cardiovasc Risk; 1999 Jun 28; 6(3):145-50. PubMed ID: 10463140
    [No Abstract] [Full Text] [Related]

  • 6. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK, Danzi S, Paul JT, Leya G, Klein I, Samarel AM.
    Circ Heart Fail; 2009 May 28; 2(3):243-52. PubMed ID: 19808346
    [Abstract] [Full Text] [Related]

  • 7. Prevention of left ventricular remodelling after acute myocardial infarction: an update.
    Rossini R, Senni M, Musumeci G, Ferrazzi P, Gavazzi A.
    Recent Pat Cardiovasc Drug Discov; 2010 Nov 28; 5(3):196-207. PubMed ID: 20874671
    [Abstract] [Full Text] [Related]

  • 8. Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats.
    Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E.
    Eur J Heart Fail; 2006 Dec 28; 8(8):790-6. PubMed ID: 16549389
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO, Pereira CA, Silva MO, Felisbino SL, Cicogna AC, Okoshi K, Aragon FF, Padovani CR, Okoshi MP, Castro AV.
    Clin Exp Pharmacol Physiol; 2009 Mar 28; 36(3):325-30. PubMed ID: 19278522
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S.
    Clin Exp Pharmacol Physiol; 2009 Mar 28; 36(3):262-6. PubMed ID: 18785976
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prediction rule for left ventricular dilatation post-MI?
    St John Sutton M, Scott CH.
    Eur Heart J; 2002 Apr 28; 23(7):509-11. PubMed ID: 11922636
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heart rate variability.
    Bilchick KC, Berger RD.
    J Cardiovasc Electrophysiol; 2006 Jun 28; 17(6):691-4. PubMed ID: 16836727
    [No Abstract] [Full Text] [Related]

  • 15. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
    Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T, Ishizaka A, Ogawa S.
    Cardiovasc Res; 2009 Feb 15; 81(3):565-73. PubMed ID: 18984601
    [Abstract] [Full Text] [Related]

  • 16. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P.
    Circ Res; 2009 Apr 10; 104(7):896-904. PubMed ID: 19246681
    [Abstract] [Full Text] [Related]

  • 17. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S, Long CL, Wang RH, Wang H.
    Cardiovasc Res; 2009 Aug 01; 83(3):444-56. PubMed ID: 19304734
    [Abstract] [Full Text] [Related]

  • 18. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T, Nagata K, Cheng XW, Obata K, Saka M, Miyachi M, Naruse K, Nishizawa T, Noda A, Izawa H, Kuzuya M, Okumura K, Murohara T, Yokota M.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):163-70. PubMed ID: 19501083
    [Abstract] [Full Text] [Related]

  • 19. A catheter based chronic porcine model of post-infarct dilated heart failure.
    Brødløs HK, Bramsen MB, Agger P, Jensen H, Bjerre M, Ringgaard S, Wierup P, Nielsen SL, Hasenkam JM, Smerup M.
    Scand Cardiovasc J; 2009 Aug 01; 43(4):260-6. PubMed ID: 19065447
    [Abstract] [Full Text] [Related]

  • 20. [Inhibitor of left ventricular remodeling].
    Kurabayashi M.
    Nihon Rinsho; 2011 Nov 01; 69 Suppl 9():246-51. PubMed ID: 22724210
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.